Champions Oncology, Inc. CSBR
Set alert
4.81 USD 0.00 0.00%
At close · Nov 2
4.92 +0.11 +2.29%
After hours · Nov 2, 4:00 PM ET
4.77 Day range 5.03
4.59 52-week range 8.31
- YTD
- -30.39%
- 1 year
- -29.26%
- Open
- 4.98
- Prev close
- 4.81
- Mkt cap
- 66.95M
- Vol
- 246
- Avg vol
- 11.03K
- EPS
- -0.07
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.77
- High
- 5.03
- Forward P/E
- 42.68
- Beta
- 0.49
- Short ratio
- 20.86
- Inst. own
- 49.09%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.71
- 200-d avg
- 4.79
- 1y target
- 8.00
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 8.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.01 | -0.01 – -0.01 | -0.16 | +93.8% | 12.93M | +7.6% | 1 |
| Next quarter | 0.06 | 0.06 – 0.06 | 0.01 | +500.0% | 15.67M | +11.9% | 1 |
| Current year | 0.21 | 0.21 – 0.21 | -0.46 | +145.6% | 56.15M | +11.9% | 1 |
| Next year | 0.24 | 0.24 – 0.24 | 0.21 | +14.3% | 61.83M | +10.1% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 12, 2024 | Craig-Hallum | Maintained | Buy | Buy |
| Sep 12, 2024 | Craig-Hallum | Upgrade | Hold | Buy |
| Mar 13, 2024 | Craig-Hallum | Downgrade | Buy | Hold |
| Sep 22, 2023 | Roth MKM | Maintained | Buy | Buy |
| Mar 15, 2021 | Roth Capital | Maintained | — | Buy |
| Nov 18, 2019 | Benchmark | Initiated | — | Speculative Buy |
| Sep 20, 2019 | Roth Capital | Initiated | — | Buy |
| Jul 24, 2019 | Janney Montgomery Scott | Downgrade | Buy | Neutral |
| Jul 17, 2018 | Craig-Hallum | Initiated | — | Buy |
| May 15, 2018 | Dawson James | Initiated | — | Buy |